131I-mIBG treatment dosimetry: dependence on the fitting expression and the role of biodosimetry

被引：0
|
作者：
Torres-Espallardo, I. [1 ]
Balaguer, J. [1 ]
Montoro, A. [1 ]
Sebastian, N. [1 ]
Loaiza, J. [1 ]
Olivas, C. [1 ]
Bautista, J. [1 ]
Adria, M. [1 ]
Ibanez, B. [1 ]
Pascual, V. [1 ]
Campayo, J. [1 ]
Villaescusa, J. [1 ]
Canete, A. [1 ]
Castel, V. [1 ]
Bello, P. [1 ]
机构：
[1] Hosp Univ & Politecn La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP496
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [41] High-Specific-Activity 131I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma
    Al-Ward, Ruaa
    Brondani, Vania Balderrama
    Sawani, Sahar
    Potter, Cheryl L.
    Xu, Guofan
    Waguespack, Steven G.
    Varghese, Jeena
    Habra, Mouhammed Amir
    Lu, Yang
    Jimenez, Camilo
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 610 - 620
  • [42] Dosimetric evidences of 131I-MIBG treatment in High Risk Neuroblastoma in VERITAS protocol
    Saletti, P.
    Olianti, C.
    Tondo, A.
    Simontacchi, G.
    Belli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S225 - S225
  • [43] Upfront Treatment of High-Risk Neuroblastoma With a Combination of 131I-MIBG and Topotecan
    Kraal, Kathelijne C. J. M.
    Tytgat, Godelieve A. M.
    van Eck-Smit, Berthe L. F.
    Kam, Boen
    Caron, Huib N.
    van Noesel, Max
    PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 1886 - 1891
  • [44] The treatment of malignant metaiodobenzylguanidine (131I-MIBG):: A comprehensive review of 116 reported patients
    Loh, KC
    Fitzgerald, PA
    Matthay, KK
    Yeo, PPB
    Price, DC
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (11) : 648 - 658
  • [45] 131I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy
    Castellani, M. R.
    Seghezzi, S.
    Chiesa, C.
    Aliberti, G. L.
    Maccauro, M.
    Seregni, E.
    Orunesu, E.
    Luksch, R.
    Bombardieri, E.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (01): : 100 - 113
  • [46] Anatomic Patterns of Relapse and Progression Following Treatment With 131I-MIBG in Metastatic Neuroblastoma
    Ben Kenan, R. Fishel
    Polishchuk, A. L.
    Hawkins, R. A.
    Braunstein, S. E.
    Matthay, K. K.
    DuBois, S. G.
    Haas-Kogan, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S196 - S196
  • [47] Transcript Analysis for Internal Biodosimetry Using Peripheral Blood from Neuroblastoma Patients Treated with 131I-mIBG, a Targeted Radionuclide
    Edmondson, David A.
    Karski, Erin E.
    Kohlgruber, Ayano
    Koneru, Harsha
    Matthay, Katherine K.
    Allen, Shelly
    Hartmann, Christine L.
    Peterson, Leif E.
    DuBois, Steven G.
    Coleman, Matthew A.
    RADIATION RESEARCH, 2016, 186 (03) : 235 - 244
  • [48] Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    Maric, Ines
    Weber, Manuel
    Prochnow, Andre
    Schmitz, Jochen
    Unger, Nicole
    Schaarschmidt, Benedikt M.
    Poeppel, Thorsten D.
    Rischpler, Christoph
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    Fendler, Wolfgang P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 885 - 891
  • [49] Sequelae and survivorship in patients treated with 131I-MIBG therapy
    Sze, W. C. C.
    Grossman, A. B.
    Goddard, I.
    Amendra, D.
    Shieh, S. C. C.
    Plowman, P. N.
    Drake, W. M.
    Akker, S. A.
    Druce, M. R.
    BRITISH JOURNAL OF CANCER, 2013, 109 (03) : 565 - 572
  • [50] Improved Tumor Dosimetry by Combining 131I-MIBG and 90Y-DOTATOC in Patients with Carcinoid Tumors
    Bushnell, David
    Madsen, Mark
    O'Dorisio, Tom
    Menda, Yusuf
    Schmitt, Beth
    Halfdanarson, Thorvardur
    O'Dorisio, Sue
    PANCREAS, 2012, 41 (02) : 343 - 343
12345